Pacific Biosciences Of California reported $103.44M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Accelerate Diagnostics AXDX:US 16.21M 6.6M
Agilent A:US $ 1247M 51M
Bruker BRKR:US $ 514.5M 16M
Danaher DHR:US $ 5546M 30M
General Electric GE:US $ 17794M 39M
Illumina ILMN:US $ 1.04B 119M
Nanostring Technologies NSTG:US $ 69.31M 760K
Pacific Biosciences Of California PACB:US $ 103.44M 7.26M
Perkinelmer PKI:US $ 978.71M 25.89M
Thermo Fisher Scientific TMO:US $ 8969M 28M
Waters WAT:US $ 514.69M 19.58M